Real-World Evidence in Practice
Real-World Evidence studies are increasingly expected to inform regulatory, safety, HEOR and Medical Affairs decisions. However, generating meaningful evidence requires more than methodological expertise.
This webinar series explores how healthcare systems, real-world data sources and operational considerations shape the design and delivery of successful RWE studies across different countries and therapeutic areas.
Expert
Speakers
Sessions delivered by leading pharmacoepidemiologists together with OXON.
Healthcare
& Data Sources
Centred on understanding healthcare and data sources to enhance the quality of RWE studies.
Real-World
Applications
Practical cases and tips for application in safety, HEOR/market access and marketing purposes.
Focused
Sessions
Complemented with specialized sessions covering specific topics related to Real-World Evidence.
Upcoming Live Sessions
Explore the webinars currently open for registration and secure your place in upcoming live sessions led by international experts in Real-World Evidence.

Wednesday,
24 June 2026
Session 02
Designing & Delivering Successful RWE Across Japan
KEY SPEAKER: Prof. Masao Iwagami
Clinical Epidemiologist and Professor at the University of Tsukuba, and Honorary Assistant Professor of Epidemiology and Population Health at the LSHTM.

Wednesday,
16 September 2026
Session 03
Designing & Delivering Successful RWE in Vaccines
KEY SPEAKER: Itziar Ubillos,
Clinical epidemiologist with a PhD in International Health from the University of Barcelona and a Master’s in Control of Infectious Diseases from LSHTM.
Past Sessions
Browse previously delivered webinars from the series and discover the topics covered and experts featured.
Thursday, 21 May 2026
Session 01
Designing & Delivering Successful RWE Across France
KEY SPEAKER: Dr Patrick Blin
Pharmaco-Epi Senior Consultant, SNDS expert and Vice-president of the Ethics and Scientific Committee for Health Research, Studies and Evaluations (CESREES)
A practical learning experience
This webinar series is delivered by OXON Epidemiology and top-tier academics to provide a structured educational experience focused on the design and conduct of primary and secondary data observational studies for safety, HEOR and market access, clinical development, orphan diseases and pregnancy research.
Other sessions in the series
Other sessions of this Webinar series include topics, such as:
Designing & Delivering Successful RWE in Vaccines
Designing & Delivering Successful RWE in the Healthcare Landscape of the UK
Designing & Delivering Successful RWE in the Healthcare Landscape of South Korea
Designing & Delivering Successful Real-World RMM & Controlled-Access Studies
Designing & Delivering Successful RWE in the Healthcare Landscape of China
Designing & Delivering Successful RWE in the Healthcare Landscape of the Nordics
Designing & Delivering Successful RWE in Pregnancy Studies
Designing & Delivering Successful RWE in the Healthcare Landscape of Taiwan
Designing & Delivering Successful RWE in the Healthcare Landscape of Germany
OXON EPIDEMIOLOGY
Your observational studies service provider
Let us help design & conduct your optimal
PASS or Outcomes observational study
OXON epidemiologists, statisticians, clinicians, and project managers (ex-big pharma), supported by Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (devised: ‘Pocock Stopping Rule’, ‘Win Ratio’. ‘Individualising benefit-risk’); extensive experience with EMA/FDA and data monitoring committees (including adaptive platform Covid-19 DISCOVERY trial); >600 publications (100+ NEJM/Lancets)
REQUEST A MEETING